SNDX - Syndax Pharmaceuticals - Loyal to the base bounce?

2 ביולי 2018

First of all, I'm in love with this chart, not like a friend, but like a secret admirer whilst in high school going thru my hormonal changes. Syndax Pharmaceuticals has consistently shown great loyalty to the bounce when it reaches lower levels, close to or under it's support. This Pharma stock has shown to have great support at about $8.00. SNDX has a couple products out right now that are in testing phases, Entinostat and the SNDX-6352. The recent 25% decline was due to the Phase 2 of the study being "unimpressive". This trial however, serves as a base for positive results for phase 3 trials, which is coming up soon. We should see some consolidation at this level until the results are provided, then a possible jump. Make sure you take profits!! We're looking at a target price on the low end of $12.00, and as high as $18.00. SNDX is currently sitting at $7.03 as I'm writing this.